Ericsson Supports Advance Global Healthcare Solutions in Singapore
The National University Health System (NUHS) and Sahlgrenska University Hospital have partnered with AstraZeneca, Ericsson, and Business Sweden to launch the Global Health Innovation Network (GHIN).
This strategic initiative aims to drive global healthcare innovation by identifying, implementing, and scaling advancements in screening, diagnosis, and monitoring technologies. The partnership was formalized through a Memorandum of Understanding (MoU) signing at the Singapore-Sweden Royal Business Forum. The signing was witnessed by Ms Miriam Söderström, Sweden’s State Secretary for Healthcare, and Ms Lai Wei Lin, Singapore’s Permanent Secretary for Policy and Development. The event was also attended by Singapore’s Minister for Health, Mr Ong Ye Kung.
GHIN represents the first concrete initiative stemming from the government-to-government MoU on healthcare innovation signed between Singapore and Sweden at the same forum. By uniting expertise from healthcare, pharmaceutical, and communication industries, GHIN will accelerate the implementation of innovative healthcare solutions, a global challenge in advancing medical innovation.
NUHS and Sahlgrenska University Hospital will jointly provide clinical expertise, hospital resources, mentoring, and research collaboration to drive the development and scaling of novel healthcare technologies. AstraZeneca, Ericsson, and Business Sweden will bring their strengths in pharmaceutical innovation, technological connectivity, and project management to support this mission.
Dr Boubou Hallberg, CEO, Sahlgrenska University Hospital
Implementing the newest technologies and leveraging opportunities from research and innovation worldwide strengthens global healthcare. This collaboration also helps new treatments reach patients from all over the world faster.
Adjunct Professor Jason Phua, Deputy Chief Executive (Clinical Transformation), NUHS
As an academic health system, we will bring together expertise in clinical care, research, and education to support this collaboration. When we combine our strengths with the unique capabilities of our partners, we can contribute meaningfully to the advancement of patient care and the improvement of global health.
Ms Kim Suyeon, Country President, AstraZeneca Singapore
We are really excited to come onboard this meaningful collaboration, leveraging AstraZeneca’s global healthcare innovation platform, A.Catalyst Network. As part of a broader network of ecosystem stakeholders, our role as a founding industry partner is to support the scouting of innovative solutions towards solving identified problem statements across the healthcare systems, potentially helping to scale effectively implemented solutions to other markets via our network.
Mr Daniel Ode, Head of Ericsson Singapore, Philippines, and Brunei
High performance connectivity based on 5G will transform healthcare. By joining the GHIN as a founding partner, we will fuel innovation in healthcare services based on our ability to blend technological innovation with medical knowledge. With 5G, we can extend the reach of the healthcare system to many people for whom healthcare access and treatment is a challenge.
link
